Roberto Grimaldi
Career history of Roberto Grimaldi
Former positions of Roberto Grimaldi
| Companies | Position | Start | End |
|---|---|---|---|
Sandoz Corp.
 Sandoz Corp. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Sandoz Corp. develops, produces, and markets medicines. | Corporate Officer/Principal | - | - |
Crucell Biologics, Inc.
 Crucell Biologics, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Crucell Biologics, Inc. is a company that manufactures and supplies biopharmaceutical products. The company is based in Miami, FL. | Corporate Officer/Principal | - | - |
Seqirus Vaccines Ltd.
 Seqirus Vaccines Ltd. BiotechnologyHealth Technology Seqirus Vaccines Ltd. manufactures vaccines. The company is headquartered in Maidenhead, the United Kingdom. | Corporate Officer/Principal | - | - |
Mucosis BV
 Mucosis BV Miscellaneous Commercial ServicesCommercial Services Mucosis BV develops mucosal vaccines for infectious diseases. Its product is SynGEM, an intranasal vaccine to prevent respiratory syncytial virus infection. Its vaccines are based on the patented and validated Mimopath technology. This technology enables a more natural immune response as well as a broad base of protection as was seen in the proof-of-concept animal and human studies of our FluGEM vaccine candidate. The company was founded by Cornelis Leenhouts in 2007 and is headquartered in Groningen, the Netherlands. | Chief Tech/Sci/R&D Officer | 31/03/2010 | - |
Training of Roberto Grimaldi
| University of Pavia | Undergraduate Degree |
Statistics
International
| United States | 3 |
| Netherlands | 2 |
| Italy | 2 |
Operational
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 4 |
|---|---|
Mucosis BV
Mucosis BV Miscellaneous Commercial ServicesCommercial Services Mucosis BV develops mucosal vaccines for infectious diseases. Its product is SynGEM, an intranasal vaccine to prevent respiratory syncytial virus infection. Its vaccines are based on the patented and validated Mimopath technology. This technology enables a more natural immune response as well as a broad base of protection as was seen in the proof-of-concept animal and human studies of our FluGEM vaccine candidate. The company was founded by Cornelis Leenhouts in 2007 and is headquartered in Groningen, the Netherlands. | Commercial Services |
Crucell Biologics, Inc.
Crucell Biologics, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Crucell Biologics, Inc. is a company that manufactures and supplies biopharmaceutical products. The company is based in Miami, FL. | Health Technology |
Seqirus Vaccines Ltd.
Seqirus Vaccines Ltd. BiotechnologyHealth Technology Seqirus Vaccines Ltd. manufactures vaccines. The company is headquartered in Maidenhead, the United Kingdom. | Health Technology |
Sandoz Corp.
Sandoz Corp. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Sandoz Corp. develops, produces, and markets medicines. | Health Technology |
- Stock Market
- Insiders
- Roberto Grimaldi
- Experience
